| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 70.173 | 58.319 | 54.982 | 58.336 | 49.825 | 55.123 | 40.645 | 45.532 | 38.912 | 32.308 |
| Total Income - EUR | 70.173 | 58.319 | 54.982 | 58.336 | 49.825 | 55.211 | 40.645 | 45.534 | 38.912 | 32.308 |
| Total Expenses - EUR | 66.088 | 60.269 | 57.605 | 60.071 | 64.335 | 50.533 | 38.597 | 41.038 | 34.397 | 31.872 |
| Gross Profit/Loss - EUR | 4.085 | -1.950 | -2.623 | -1.735 | -14.510 | 4.678 | 2.048 | 4.496 | 4.515 | 436 |
| Net Profit/Loss - EUR | 1.965 | -2.536 | -3.177 | -2.322 | -15.017 | 4.151 | 1.647 | 3.132 | 3.769 | 114 |
| Employees | 3 | 3 | 3 | 3 | 3 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Farmacia Nr.30 Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 13.538 | 12.735 | 11.865 | 11.005 | 10.687 | 9.796 | 8.906 | 8.282 | 7.616 | 6.936 |
| Current Assets | 24.974 | 14.521 | 11.355 | 11.097 | 11.638 | 10.982 | 9.489 | 9.990 | 8.520 | 9.263 |
| Inventories | 13.709 | 9.233 | 9.217 | 10.368 | 11.533 | 10.632 | 8.672 | 9.574 | 7.196 | 7.330 |
| Receivables | 59 | 74 | 64 | 92 | 51 | 63 | 87 | 282 | 76 | 0 |
| Cash | 11.206 | 5.215 | 2.074 | 637 | 54 | 287 | 730 | 135 | 1.248 | 1.933 |
| Shareholders Funds | 36.466 | 24.933 | 21.333 | 18.620 | 3.242 | 7.331 | 8.816 | 11.974 | 15.707 | 15.733 |
| Social Capital | 1.071 | 1.060 | 1.042 | 1.023 | 1.003 | 984 | 962 | 965 | 962 | 957 |
| Debts | 2.046 | 2.323 | 1.886 | 3.482 | 19.082 | 13.446 | 9.579 | 6.298 | 429 | 2.052 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7500 - 7500" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Farmacia Nr.30 Srl